Microtubule-associated protein (MAP)1B-heterozygous (MAP1B+/-) mice are deficient in the expression of MAP1B in the hippocampus, cerebellum, and olfactory cortex. Although MAP1B+/- mice showed half the normal levels of MAP1B protein, they had no measurable amounts of phosphorylated MAP1B. High-frequency theta burst stimulation of Schaffer collateral-CA1 axons in hippocampal slices from MAP1B+/- mice elicited long-term potentiation (LTP) that decayed rapidly to baseline, in contrast to the non-decremental LTP exhibited by age-matched wild-type slices. A separate group of MAP1B+/- and wild-type slices was examined for a longer time course of 3 hr post-tetanus in response to multiple high-frequency stimulus trains that induced saturated LTP. MAP1B+/- slices showed marked reductions in both immediate post-tetanic potentiation and LTP that decayed much more rapidly than that in wild-type slices. The induction of LTP was associated with a rapid dephosphorylation of MAP1B within 5-15 min post-tetanus, suggesting that the normal expression of MAP1B and conversion to a dephosphorylated state may be a cellular mediator of cytoskeletal alterations necessary for long-term activity-dependent synaptic plasticity.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jnr.20624DOI Listing

Publication Analysis

Top Keywords

map1b+/- mice
12
wild-type slices
12
long-term potentiation
8
microtubule-associated protein
8
expression map1b
8
potentiation ltp
8
ltp decayed
8
decayed rapidly
8
map1b+/-
5
map1b
5

Similar Publications

Putting the brakes on axonal branching.

Trends Neurosci

July 2024

Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address:

In a recent study, Ziak et al. employed precise sparse labeling and spatiotemporally controlled genetic manipulations to uncover novel regulators of axon branching of layer 2/3 mouse callosal projection neurons. The authors elucidated a cell-autonomous signaling pathway wherein glycogen synthase kinase 3β (GSK3β) phosphorylation of microtubule-associated protein 1B (MAP1B) restricts interstitial axon branching by modulating microtubule (MT) tyrosination status.

View Article and Find Full Text PDF

FMRP regulates postnatal neuronal migration via MAP1B.

Elife

May 2024

Sorbonne Université, CNRS UMR8246, Inserm U1130, Institut de Biologie Paris Seine (IBPS), Neuroscience Paris Seine (NPS), Paris, France.

Article Synopsis
  • Fragile X syndrome (FXS) is the most common inherited intellectual disability and a leading genetic cause of autism, linked to a lack of the protein FMRP.
  • Research using mice lacking FMRP shows that its absence causes delays and changes in neuron movement during brain development, along with issues in centrosome positioning.
  • Targeting the mRNA for MAP1B can correct these migration issues, suggesting that FMRP and MAP1B work together to manage the microtubule structure critical for proper neuronal migration.
View Article and Find Full Text PDF

RNA-binding proteins (RBPs) contribute to the pathogenesis of proliferative diabetic retinopathy (PDR) by regulating gene expression through alternative splicing events (ASEs). However, the RBPs differentially expressed in PDR and the underlying mechanisms remain unclear. Thus, this study aimed to identify the differentially expressed genes in the neovascular membranes (NVM) and retinas of patients with PDR.

View Article and Find Full Text PDF

Autoimmune central nervous system disorders: Antibody testing and its clinical utility.

Clin Biochem

April 2024

Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address:

A rapidly expanding repertoire of neural antibody biomarkers exists for autoimmune central nervous system (CNS) disorders. Following clinical recognition of an autoimmune CNS disorder, the detection of a neural antibody facilitates diagnosis and informs prognosis and management. This review considers the phenotypes, diagnostic assay methodologies, and clinical utility of neural antibodies in autoimmune CNS disorders.

View Article and Find Full Text PDF
Article Synopsis
  • * Reducing MAP1B levels in TNBC cells hinders their ability to migrate and invade, which negatively affects tumor growth.
  • * MAP1B interacts with proteins involved in invadopodia formation and microtubules, suggesting it plays a central role in promoting cancer aggressiveness in TNBC, indicating a potential target for diagnosis and treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!